Document Detail


Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446.
MedLine Citation:
PMID:  22521544     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A relatively novel paradigm in tumor biology hypothesizes that cancer growth is driven by tumor cells with stem-like properties. However, direct proof of a population of stem cells in small cell lung cancer (SCLC) remains elusive. In this study, we enriched for stem-like cells from the SCLC cell line H446 by growing them as spheres in a defined serum-free medium. Sphere-derived cells have increased in vitro clonogenic and in vivo tumorigenic potentials as well as drug-resistant properties. After enrichment for stem-like cells, we used multiple candidate stem cell markers to examine the expression profile and found that the sphere-derived cells contained a higher proportion of cells expressing the stem cell surface markers uPAR and CD133 when compared with parental cells. To identify a selectable marker for the sphere-forming cells, we evaluated the sphere-forming abilities of uPAR(+) and uPAR(-) cells as well as the sphere-forming abilities of CD133(+) and CD133(-) cells. Both CD133(+) and CD133(-) cell fractions were capable of forming spheres, and no statistically significant difference was observed in the sphere-forming efficiency between these two populations. In contrast, cells derived from the uPAR(+) fraction were capable of forming spheres, whereas cells derived from the uPAR(-) fraction remained as single cells. Moreover, uPAR(+) cells efficiently formed transplantable tumors, whereas uPAR(-) cells were unable to initiate tumors when transplanted at equivalent cell numbers. In addition, uPAR(+) cells could differentiate into CD56(+) cells, CK(+) cells, and uPAR(-) cells. These data support the existence of a population of tumor sphere-forming cells with stem cell properties in the H446 SCLC cell line. Furthermore, the stem cell population may be enriched in cells expressing the uPAR cell surface marker.
Authors:
Xiaofei Qiu; Zhengyan Wang; Yanlei Li; Yajing Miao; Yu Ren; Yajing Luan
Related Documents :
22361884 - The developmental plasticity of colocalization pattern of peptide yy and glucagon-like ...
21429724 - Hexane/ethanol extract of glycyrrhiza uralensis and its active compound isoangustone a ...
16628474 - Extranodal marginal zone b-cell lymphoma mimicking meningioma in lateral ventricle: a c...
10097694 - Microglandular hyperplasia of the uterine cervix. cytologic diagnosis in cervical smears.
15590114 - Endogenous thiols and mrp transporters contribute to hg2+ efflux in hgcl2-treated tubul...
8544774 - Biological effects of human growth hormone in rat adipocyte precursor cells and newly d...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-17
Journal Detail:
Title:  Cancer letters     Volume:  -     ISSN:  1872-7980     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600053     Medline TA:  Cancer Lett     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ireland Ltd.
Affiliation:
Department of Pathology, Tianjin Medical University, Tianjin, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FR...
Next Document:  Breast cancer, side population cells and ABCG2 expression.